nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Gastrointestinal ulcer haemorrhage—Fluorouracil—skin cancer	0.0676	0.0676	CcSEcCtD
Potassium Canrenoate—Pregnancy—Imiquimod—skin cancer	0.0414	0.0414	CcSEcCtD
Potassium Canrenoate—Slurred speech—Fluorouracil—skin cancer	0.029	0.029	CcSEcCtD
Potassium Canrenoate—Ulcer—Imiquimod—skin cancer	0.0248	0.0248	CcSEcCtD
Potassium Canrenoate—Apathy—Temozolomide—skin cancer	0.0197	0.0197	CcSEcCtD
Potassium Canrenoate—Flat affect—Temozolomide—skin cancer	0.0195	0.0195	CcSEcCtD
Potassium Canrenoate—Extravasation—Bleomycin—skin cancer	0.0191	0.0191	CcSEcCtD
Potassium Canrenoate—Extravasation—Dactinomycin—skin cancer	0.0178	0.0178	CcSEcCtD
Potassium Canrenoate—Ulcer—Bleomycin—skin cancer	0.0176	0.0176	CcSEcCtD
Potassium Canrenoate—Ulcer—Dactinomycin—skin cancer	0.0164	0.0164	CcSEcCtD
Potassium Canrenoate—Extravasation—Fluorouracil—skin cancer	0.0148	0.0148	CcSEcCtD
Potassium Canrenoate—Phlebitis—Bleomycin—skin cancer	0.014	0.014	CcSEcCtD
Potassium Canrenoate—Ulcer—Fluorouracil—skin cancer	0.0137	0.0137	CcSEcCtD
Potassium Canrenoate—Dysarthria—Fluorouracil—skin cancer	0.0137	0.0137	CcSEcCtD
Potassium Canrenoate—Pain—Vismodegib—skin cancer	0.0136	0.0136	CcSEcCtD
Potassium Canrenoate—Ileus—Docetaxel—skin cancer	0.0132	0.0132	CcSEcCtD
Potassium Canrenoate—Phlebitis—Dactinomycin—skin cancer	0.0131	0.0131	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Vismodegib—skin cancer	0.013	0.013	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Vismodegib—skin cancer	0.0126	0.0126	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Imiquimod—skin cancer	0.0118	0.0118	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Imiquimod—skin cancer	0.0118	0.0118	CcSEcCtD
Potassium Canrenoate—Asthenia—Vismodegib—skin cancer	0.0114	0.0114	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vismodegib—skin cancer	0.0109	0.0109	CcSEcCtD
Potassium Canrenoate—Extravasation—Docetaxel—skin cancer	0.0107	0.0107	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Imiquimod—skin cancer	0.0105	0.0105	CcSEcCtD
Potassium Canrenoate—Vomiting—Vismodegib—skin cancer	0.0101	0.0101	CcSEcCtD
Potassium Canrenoate—Rash—Vismodegib—skin cancer	0.01	0.01	CcSEcCtD
Potassium Canrenoate—Dermatitis—Vismodegib—skin cancer	0.01	0.01	CcSEcCtD
Potassium Canrenoate—Infection—Vemurafenib—skin cancer	0.00975	0.00975	CcSEcCtD
Potassium Canrenoate—Nausea—Vismodegib—skin cancer	0.00944	0.00944	CcSEcCtD
Potassium Canrenoate—Hypotension—Vemurafenib—skin cancer	0.00917	0.00917	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Fluorouracil—skin cancer	0.00894	0.00894	CcSEcCtD
Potassium Canrenoate—Discomfort—Imiquimod—skin cancer	0.00863	0.00863	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Bleomycin—skin cancer	0.00841	0.00841	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Bleomycin—skin cancer	0.00837	0.00837	CcSEcCtD
Potassium Canrenoate—Infection—Imiquimod—skin cancer	0.00832	0.00832	CcSEcCtD
Potassium Canrenoate—Phlebitis—Docetaxel—skin cancer	0.00788	0.00788	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Vemurafenib—skin cancer	0.00776	0.00776	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Imiquimod—skin cancer	0.00752	0.00752	CcSEcCtD
Potassium Canrenoate—Pain—Imiquimod—skin cancer	0.00716	0.00716	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Temozolomide—skin cancer	0.0071	0.0071	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Temozolomide—skin cancer	0.00706	0.00706	CcSEcCtD
Potassium Canrenoate—Asthenia—Vemurafenib—skin cancer	0.00704	0.00704	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Imiquimod—skin cancer	0.0069	0.0069	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Imiquimod—skin cancer	0.00685	0.00685	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vemurafenib—skin cancer	0.00672	0.00672	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Imiquimod—skin cancer	0.00662	0.00662	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Imiquimod—skin cancer	0.00662	0.00662	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Fluorouracil—skin cancer	0.00654	0.00654	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Fluorouracil—skin cancer	0.00651	0.00651	CcSEcCtD
Potassium Canrenoate—Vomiting—Vemurafenib—skin cancer	0.00624	0.00624	CcSEcCtD
Potassium Canrenoate—Rash—Vemurafenib—skin cancer	0.00619	0.00619	CcSEcCtD
Potassium Canrenoate—Dermatitis—Vemurafenib—skin cancer	0.00618	0.00618	CcSEcCtD
Potassium Canrenoate—Discomfort—Bleomycin—skin cancer	0.00613	0.00613	CcSEcCtD
Potassium Canrenoate—Asthenia—Imiquimod—skin cancer	0.00601	0.00601	CcSEcCtD
Potassium Canrenoate—Confusional state—Bleomycin—skin cancer	0.006	0.006	CcSEcCtD
Potassium Canrenoate—Infection—Bleomycin—skin cancer	0.00591	0.00591	CcSEcCtD
Potassium Canrenoate—Nausea—Vemurafenib—skin cancer	0.00583	0.00583	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Fluorouracil—skin cancer	0.00581	0.00581	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Imiquimod—skin cancer	0.00573	0.00573	CcSEcCtD
Potassium Canrenoate—Discomfort—Dactinomycin—skin cancer	0.00572	0.00572	CcSEcCtD
Potassium Canrenoate—Hypotension—Bleomycin—skin cancer	0.00556	0.00556	CcSEcCtD
Potassium Canrenoate—Infection—Dactinomycin—skin cancer	0.00551	0.00551	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Bleomycin—skin cancer	0.00534	0.00534	CcSEcCtD
Potassium Canrenoate—Vomiting—Imiquimod—skin cancer	0.00532	0.00532	CcSEcCtD
Potassium Canrenoate—Rash—Imiquimod—skin cancer	0.00528	0.00528	CcSEcCtD
Potassium Canrenoate—Dermatitis—Imiquimod—skin cancer	0.00527	0.00527	CcSEcCtD
Potassium Canrenoate—Discomfort—Temozolomide—skin cancer	0.00517	0.00517	CcSEcCtD
Potassium Canrenoate—Pain—Bleomycin—skin cancer	0.00509	0.00509	CcSEcCtD
Potassium Canrenoate—Confusional state—Temozolomide—skin cancer	0.00506	0.00506	CcSEcCtD
Potassium Canrenoate—Infection—Temozolomide—skin cancer	0.00498	0.00498	CcSEcCtD
Potassium Canrenoate—Nausea—Imiquimod—skin cancer	0.00497	0.00497	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Bleomycin—skin cancer	0.0049	0.0049	CcSEcCtD
Potassium Canrenoate—Discomfort—Fluorouracil—skin cancer	0.00476	0.00476	CcSEcCtD
Potassium Canrenoate—Pain—Dactinomycin—skin cancer	0.00474	0.00474	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Docetaxel—skin cancer	0.00472	0.00472	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Bleomycin—skin cancer	0.0047	0.0047	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Docetaxel—skin cancer	0.0047	0.0047	CcSEcCtD
Potassium Canrenoate—Confusional state—Fluorouracil—skin cancer	0.00466	0.00466	CcSEcCtD
Potassium Canrenoate—Infection—Fluorouracil—skin cancer	0.00459	0.00459	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Dactinomycin—skin cancer	0.00457	0.00457	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Dactinomycin—skin cancer	0.00454	0.00454	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Temozolomide—skin cancer	0.0045	0.0045	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Dactinomycin—skin cancer	0.00438	0.00438	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Dactinomycin—skin cancer	0.00438	0.00438	CcSEcCtD
Potassium Canrenoate—Hypotension—Fluorouracil—skin cancer	0.00432	0.00432	CcSEcCtD
Potassium Canrenoate—Pain—Temozolomide—skin cancer	0.00429	0.00429	CcSEcCtD
Potassium Canrenoate—Asthenia—Bleomycin—skin cancer	0.00427	0.00427	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Docetaxel—skin cancer	0.0042	0.0042	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Fluorouracil—skin cancer	0.00415	0.00415	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Temozolomide—skin cancer	0.00413	0.00413	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Temozolomide—skin cancer	0.0041	0.0041	CcSEcCtD
Potassium Canrenoate—Asthenia—Dactinomycin—skin cancer	0.00398	0.00398	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Temozolomide—skin cancer	0.00397	0.00397	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Temozolomide—skin cancer	0.00397	0.00397	CcSEcCtD
Potassium Canrenoate—Pain—Fluorouracil—skin cancer	0.00395	0.00395	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Fluorouracil—skin cancer	0.00381	0.00381	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Dactinomycin—skin cancer	0.0038	0.0038	CcSEcCtD
Potassium Canrenoate—Vomiting—Bleomycin—skin cancer	0.00378	0.00378	CcSEcCtD
Potassium Canrenoate—Rash—Bleomycin—skin cancer	0.00375	0.00375	CcSEcCtD
Potassium Canrenoate—Dermatitis—Bleomycin—skin cancer	0.00375	0.00375	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Fluorouracil—skin cancer	0.00365	0.00365	CcSEcCtD
Potassium Canrenoate—Asthenia—Temozolomide—skin cancer	0.0036	0.0036	CcSEcCtD
Potassium Canrenoate—Nausea—Bleomycin—skin cancer	0.00353	0.00353	CcSEcCtD
Potassium Canrenoate—Vomiting—Dactinomycin—skin cancer	0.00353	0.00353	CcSEcCtD
Potassium Canrenoate—Rash—Dactinomycin—skin cancer	0.0035	0.0035	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Temozolomide—skin cancer	0.00343	0.00343	CcSEcCtD
Potassium Canrenoate—Confusional state—Docetaxel—skin cancer	0.00336	0.00336	CcSEcCtD
Potassium Canrenoate—Infection—Docetaxel—skin cancer	0.00331	0.00331	CcSEcCtD
Potassium Canrenoate—Nausea—Dactinomycin—skin cancer	0.00329	0.00329	CcSEcCtD
Potassium Canrenoate—Vomiting—Temozolomide—skin cancer	0.00319	0.00319	CcSEcCtD
Potassium Canrenoate—Rash—Temozolomide—skin cancer	0.00316	0.00316	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Fluorouracil—skin cancer	0.00316	0.00316	CcSEcCtD
Potassium Canrenoate—Dermatitis—Temozolomide—skin cancer	0.00316	0.00316	CcSEcCtD
Potassium Canrenoate—Hypotension—Docetaxel—skin cancer	0.00312	0.00312	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Docetaxel—skin cancer	0.003	0.003	CcSEcCtD
Potassium Canrenoate—Nausea—Temozolomide—skin cancer	0.00298	0.00298	CcSEcCtD
Potassium Canrenoate—Vomiting—Fluorouracil—skin cancer	0.00294	0.00294	CcSEcCtD
Potassium Canrenoate—Rash—Fluorouracil—skin cancer	0.00291	0.00291	CcSEcCtD
Potassium Canrenoate—Dermatitis—Fluorouracil—skin cancer	0.00291	0.00291	CcSEcCtD
Potassium Canrenoate—Pain—Docetaxel—skin cancer	0.00285	0.00285	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Docetaxel—skin cancer	0.00275	0.00275	CcSEcCtD
Potassium Canrenoate—Nausea—Fluorouracil—skin cancer	0.00275	0.00275	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Docetaxel—skin cancer	0.00273	0.00273	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Docetaxel—skin cancer	0.00264	0.00264	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Docetaxel—skin cancer	0.00264	0.00264	CcSEcCtD
Potassium Canrenoate—Asthenia—Docetaxel—skin cancer	0.00239	0.00239	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Docetaxel—skin cancer	0.00228	0.00228	CcSEcCtD
Potassium Canrenoate—Vomiting—Docetaxel—skin cancer	0.00212	0.00212	CcSEcCtD
Potassium Canrenoate—Rash—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Potassium Canrenoate—Dermatitis—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Potassium Canrenoate—Nausea—Docetaxel—skin cancer	0.00198	0.00198	CcSEcCtD
